Colgate-Palmolive (NYSE:CL) Shares Sold by Glenview Trust co

Glenview Trust co cut its stake in shares of Colgate-Palmolive (NYSE:CL) by 7.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,207 shares of the company’s stock after selling 1,100 shares during the period. Glenview Trust co’s holdings in Colgate-Palmolive were worth $1,292,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Chicago Partners Investment Group LLC boosted its stake in shares of Colgate-Palmolive by 16.2% in the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after purchasing an additional 943 shares during the period. Peak Financial Advisors LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $1,315,000. Fiduciary Alliance LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $4,066,000. Impact Partnership Wealth LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $803,000. Finally, Barclays PLC boosted its stake in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently issued reports on CL. UBS Group decreased their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Friday. Morgan Stanley decreased their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and a consensus price target of $101.72.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $90.72 on Tuesday. The firm’s fifty day simple moving average is $89.09 and its 200-day simple moving average is $94.56. The stock has a market capitalization of $73.62 billion, a price-to-earnings ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the business posted $0.87 EPS. As a group, equities analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.